Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | L-685458 | CCLE | pan-cancer | AAC | 0.017 | 0.7 |
mRNA | Mitomycin-C | CTRPv2 | pan-cancer | AAC | 0.012 | 0.7 |
mRNA | Methotrexate | FIMM | pan-cancer | AAC | 0.049 | 0.7 |
mRNA | BI-2536 | FIMM | pan-cancer | AAC | -0.047 | 0.7 |
mRNA | linifanib | GDSC1000 | pan-cancer | AAC | 0.013 | 0.7 |
mRNA | BRD-K79669418 | CTRPv2 | pan-cancer | AAC | -0.019 | 0.7 |
mRNA | AC220 | GDSC1000 | pan-cancer | AAC | 0.012 | 0.7 |
mRNA | BRD9876 | CTRPv2 | pan-cancer | AAC | 0.014 | 0.7 |
mRNA | Vandetanib | CCLE | pan-cancer | AAC | 0.016 | 0.7 |
mRNA | Panobinostat | CCLE | pan-cancer | AAC | -0.014 | 0.7 |